ʻO ka'ōmole Palwene Palmitoylethanolamide (544-31-0) wikiō
Paheʻe Palmitoylethanolamide (544-31-0) Snāʻike
| Product Name | ʻO ka pāpaʻi Palwōthylethanolamide |
| Hawaiian Name | Māla Palmitoylethanolamide lepo;
(2-Hydroxyethyl) hexadecanamide; Hydroxyethyllpalmitamide; ʻO ka Palmidrol; N-Palmitocylethanolamine; |
| Brand Name | ʻAʻoheʻikepili no ka loaʻa |
| Kōpana Drug | ʻAmine, Nā lāʻau lapaʻau, Nā waena & Nā Kemika Maʻemaʻe |
| Kāleka CAS | 544-31-0 |
| InChIKey | HXYVTAGFYLMHSO-UHFFFAOYSA-N |
| hakakino F'Oula | C18H37NO2 |
| hakakino Wʻewalu | 299.499 g / mole |
| Monoisotopic Mass | 299.50 Bi / mol |
| Hoʻolaha Pʻo kaʻaila | 93 a 98 ° C (199 a 208 ° F; 366 a 371 K) |
| ʻO ka paila | 461.5 ° C ma 760 mmHg |
| ʻO ka Halifa-Ola | ʻAʻoheʻikepili i loaʻa |
| kala like 'ole | Kūleʻa i ka Paʻa Loa-White |
| Solakino | Kaʻikepili (Sparingly), Methanol (Mākaukau) |
| Ska hoʻokele Tka mahana | -20 ° C |
| Pawīwī Palmitoylethanolamide Apaukū | ʻO ka palapa Palmitoylethanolamide he mea maʻi nui CB2 cannabinoid diabolor agonist a kohoʻo GPR55 agonist. |
Paheʻe Palmitoylethanolamide (544-31-0) Hōʻike
ʻO ka pāpaʻi Palmitoylethanolamide (PEA) he mea momona momona acide, no ka papa o nā mea hana'āpana hoʻonāuki. Hāʻawiʻia ka Palmitocylethanolamide (PEA) i loko o ke kino no ka paleʻana i kaʻeha a me ka mumū. Nui nā holoholona a me nā mea kanu e hua mai i ka PEA. Hiki ke loaʻa nā helu kiʻekiʻe loa i ka lecithin soy, soybeans, yolk egg, peanuts, and alfalfa. Hiki i kēia'alekoʻa momona ke hoʻoulu pono i kāu cannabino a me ka paleʻana i nā aʻalolo i loko o kou kino. He mea hōʻoluʻolu kona mau pono no kahi maʻi nui o ka maʻi.
Ua hōʻike ʻia ʻo Palmitoylethanolamide e hoʻopaʻa i kahi mea loaʻa i ka cell-nucleus (kahi receptor nukelea) a hana i nā ʻano hana olaola he nui e pili ana i ka ʻeha mau a me ka mumū. ʻO ka pahuhopu nui i manaʻo ʻia ʻo ka alpha receptor activated peroxisome proliferator-activated alpha (PPAR-α). Eia nō naʻe, ua ʻike ʻia ke kū ʻana o Palmitoylethanolamide (a me nā ʻano N-acylethanolamines) e hoʻonui ai i ka hana anandamide e kahi "entourage effect" i kapa ʻia. Hōʻike ʻia ka Raw Palmitoylethanolamide pauka / PEA i nā anti-inflammatory, anti-nociceptive, neuroprotective, a me nā anticonvulsant.
Ma keʻano he waihona, hiki ke loaʻa ka PEA ma ka papapala, ka capsule, a me ka paukū. I Italia a me Sepania, ua kūʻai 'ia ka PEA ma ke' ano he meaʻai no nā kumu hana lapaʻau kūikawā.
Paheʻe Palmitocylethanolamide (544-31-0) Mākaukau hana.
Paʻi ka Palmitoylethanolamide i ka hoʻonuiʻana i ka ikaika, momona momona, a me ka'āpana PPAR anti-inflammatory. Ma ka hoʻonāʻana i kēia kīlalā kī, hoʻomau ka PEA i ka hana o nā'ōpala pro-inflammatory a me ka hanaʻana o nā mea he nui inflammatory.
Paʻi ka Palmitocylethanolamide i ka hana o ka momona FAAH e hoʻohaki i ka anandamide cannabinoid. ʻO kēia ka hoʻonui i ke kiʻekiʻe o ka hoʻonaniʻana i ka anandamide i loko o kou kino, e kōkua ana i ka pale i kaʻeha a hoʻonui i ka hoʻomaha. Hiki iā ia ke hoʻoikaika i nā pūnaʻi cannabinoid (CB2 a me CB1).
Aia ka Palmitocylethanolamide i ka palmitic acid i loko o kona hale. ʻO ka hoʻomakaʻana no ka hana PEA i loko o ke kino,ʻo ia kaʻaila wai momona.
Eia nō naʻe, ʻo ka hoʻonui ʻana i kāu lawe ʻana i ka waikawa palmitic a i ʻole nā mea momona ʻē aʻe ʻaʻole e hoʻopili ka Palmitoylethanolamide i ka hana. ʻO kēia no ka hoʻohana ʻana o kou kino i ka PEA ke pono ia e uku no ka mumū a i ʻole ʻeha, a ʻokoʻa hoʻi nā pae i ka lā holoʻokoʻa. ʻO ke ala ʻoi loa e loaʻa ai nā pōmaikaʻi o ka PEA i nā mea hoʻopili maʻamau, a i ʻole nā meaʻai waiwai PEA.
hoʻohana ʻo ka palaʻa Palmitocylethanolamide (544-31-0)
▪ Mālama ʻeha
▪ Pākuʻi kūpikipiki
▪ Kūʻē anti-nociceptive
▪ Neuroprotective
▪ Nā waiwai anticonvulsant.
Hōʻikeʻia ka papa helu Palmitoylethanolamide (544-31-0) Hoʻoponopono
ʻO nāʻoihana olakino hou aku he mea maikaʻi akā akā, ua lawa kaʻikepili e'ōlelo aiʻo Palmitoylethanolamide kahi hōʻailona palekana loa. ʻO ka PEA hoʻolālā lōʻihiʻole e pili ana i kekahi hopena pilikia. Ua hoʻohanaʻia ka Palmitocylethanolamide ma nā doses o 300 mg i ka 1.8 g / lā ma nā noi noiʻi.
▪ Ma ka liʻiliʻi he 600 mg / lā e pono ai e hōʻoluʻolu i ka ʻeha o ke aʻalolo, ʻoiai ʻo 1.2 g / lā i hoʻohana ʻia no ka ʻeha nerve diabetic.
▪ Hoʻohana ʻia ka PEA a i ka 1.8 g / lā no ka hōʻemi ʻana i nā ʻino o ka maka i ka poʻe me ka glaucoma a i ʻole ka maʻi diabetes.
▪ No ka hakakā ʻana i ke anuanu maʻamau, 1.2 g / lā ka maʻa maʻamau.
▪ Hiki ke hoʻokaʻawale ʻia ka huina lāʻau i ʻelua i ke ao. Paipai mākou e hoʻomaka me ke ana maʻamau o 1.2 g / lā i māhele ʻia i 600 mg i ke kakahiaka a me 600 mg i ka ʻauinalā. E nānā i kāu pane a hoʻonui iki i nā mea ma hope o 1 mau mahina inā pono.
Ua hoʻohanaʻia nā pāpili Palmitoylethanolamide i kōkoʻoʻia ma kaʻike nuiʻana i nāʻano likeʻole. ʻO ka Palmitoylethanolamide kōkōʻia he lepo maikaʻi iʻoi aku ka maikaʻi a me ka maikaʻi. Ua hoʻohana pūʻia ka Palmitocylethanolamide me ka luteolin i loko o nā ho'āʻo hoʻokolohua a he mea nui loa ia no ka ola kino.
pomaikai o Paheʻe Palmitocylethanolamide (544-31-0)
Mai kona loaʻa ʻana i nā makahiki 1950, ua pīhoihoi nā kānaka noiʻi me Palmitoylethanolamide. Ma ke ʻano he painkiller kūlohelohe ikaika a palekana hoʻi a me anti-inflammatory, Palmitoylethanolamide hāʻawi i ka manaʻolana no ka nui o nā poʻe e ʻeha nei i ka maʻi maʻi mau a me nā neuropathic. Koe kēia pōmaikaʻi, Palmitoylethanolamide kaola e hāʻawi i nā pono kūpono no kou olakino pilikino. Aia kekahi mau pono no ke kuhikuhi ʻana:
♦ PEA hoʻemi i ka ʻeha a me ka mumū
♦ Hoʻonui i ke olakino olakino a me ka hoʻohou hou ʻana
♦ Maikaʻi no kou mau maka
♦ Maluhia paha i kou puʻuwai
♦ Hoʻoemi i ka huhū Gut
♦ Hiki ke hōʻemi i nā ʻōuli kaumaha.
♦ Hoʻemi i nā ʻōuli o Multiple Sclerosis
♦ Kaua paha i ke anuanu maʻamau
♦ Hoʻemi i ka hoʻokuʻu o Histamine
Ke hoʻomau nei e ʻike ʻia nā pōmaikaʻi hou o Palmitoylethanolamide, me ka haʻalele ʻana i kekahi mau ʻepekema. ʻIke ʻia e hiki i ka Palmitoylethanolamide ke hoʻoulu i nā mea loaʻa cannabinoid, hoʻomaikaʻi i ke ʻano, hoʻoliʻiliʻi i nā maʻi āpau.
He aha nā ʻike ma Palmitoylethanolamide (PEA) i loaʻa he pono no ka nalowale kaumaha?
